Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge

This publication has 34 references indexed in Scilit:

• Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention
  BMJ, 2005
• Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997
  Circulation, 2001
• Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled Trial
  JAMA, 2001
• Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations
  The Lancet, 2000
• Trends in the Incidence of Myocardial Infarction and in Mortality Due to Coronary Heart Disease, 1987 to 1994
  New England Journal of Medicine, 1998
• Improved Outcome of Elderly Patients (≥75 Years of Age) With Acute Myocardial Infarction From 1981-1983 to 1992-1994 in Israel
  Circulation, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial Infarction
  New England Journal of Medicine, 1992
• Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease
  Published by American Medical Association (AMA) ,1991
• Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial Infarction
  New England Journal of Medicine, 1988